CPH 0.00% 0.9¢ creso pharma limited

Ann: Quarterly Update and Appendix 4C, page-5

  1. 227 Posts.
    lightbulb Created with Sketch. 46
    I like how they reported revenue comparison to quarter1 2019 and not quarter4 2019.. which had a revenue drop from $1.7m to $1.1m - Adding lots of new products to make up for other failing products is not a sustainable strategy.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.